Table 4.
Clinical Indication | Amino acid Radiopharmaceutical | Method | Threshold | Reference |
---|---|---|---|---|
Differentiation between neoplastic a non-neoplastic brain lesion | [18F]FET | TBRmax | 1.6 | [71] |
[11C]MET | TBR max | 1–1.5 | [56, 58, 102] | |
[18F]DOPA | TBRmax | 1 | [81, 82] | |
Tumour Grading | [18F]FET | TAC curve shape | N.A | [72] |
[11C]MET | N.R | N.R | ||
[18F]DOPA | TSRmax | 1 | [81, 82] | |
Prognostic value | [18F]FET | TBR max and TAC curve shape | 1.6 | [71, 72] |
[11C]MET | SUVmax | 3 | [65] | |
[18F]DOPA | TSRmax | 1 | [81, 82] | |
Tumour Relapse | [18F]FET | TBRmax | 1.6 | [71] |
[11C]MET | SUVmax | 3 | [65] | |
[18F]DOPA | Not available | Not available | Not available |
N.R. = not reported, N.A. = not applicable
N.R. = not reported, N.A. = not applicable